This article is more than 5 years old. Information may no longer be current.

VIDEO: SightLife Surgical announces two major partnerships

Issue: June 25, 2017

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

LOS ANGELES – SightLife Surgical announced partnerships with Imprimis and Shigeru Kinoshita, MD, PhD, President and CEO Monty Montoya said at the Ophthalmology Innovation Summit at ASCRS here. Under the Imprimis agreement the companies will work together to offer autologous Serum Tears across the United States. The goal of the latter agreement is to develop Kinoshita’s injectable endothelial therapy and bring it to the U.S.